iRhythm Technologies to Report First Quarter 2025 Financial Results on May 1, 2025
iRhythm Technologies (NASDAQ:IRTC), a digital health care company specializing in disease detection, prevention, and prediction solutions, has scheduled its first quarter 2025 financial results announcement for May 1, 2025, after market close.
The company will host a conference call with management at 1:30 p.m. PT / 4:30 p.m. ET on the same day. Investors can access both live and archived versions of the conference call through the 'Quarterly Results' section on iRhythm's investor website at investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC), un'azienda nel settore della salute digitale specializzata in soluzioni per la rilevazione, prevenzione e previsione delle malattie, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 1° maggio 2025, dopo la chiusura del mercato.
La società terrà una conference call con il management alle 13:30 PT / 16:30 ET dello stesso giorno. Gli investitori potranno accedere sia alla versione in diretta sia a quella registrata della conference call nella sezione 'Quarterly Results' del sito dedicato agli investitori di iRhythm all'indirizzo investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC), una empresa de salud digital especializada en soluciones para la detección, prevención y predicción de enfermedades, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 1 de mayo de 2025, después del cierre del mercado.
La compañía realizará una conferencia telefónica con la dirección a las 1:30 p.m. PT / 4:30 p.m. ET del mismo día. Los inversores podrán acceder tanto a la versión en vivo como a la grabada de la conferencia a través de la sección 'Quarterly Results' en el sitio web para inversores de iRhythm en investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC)는 질병 감지, 예방 및 예측 솔루션을 전문으로 하는 디지털 헬스케어 기업으로, 2025년 1분기 재무 결과 발표를 2025년 5월 1일 시장 마감 후에 예정하고 있습니다.
회사는 같은 날 오후 1:30 PT / 오후 4:30 ET에 경영진과의 컨퍼런스 콜을 진행할 예정입니다. 투자자들은 iRhythm 투자자 웹사이트 investors.irhythmtech.com의 'Quarterly Results' 섹션에서 실시간 및 녹화된 컨퍼런스 콜 모두에 접속할 수 있습니다.
iRhythm Technologies (NASDAQ:IRTC), une entreprise de santé numérique spécialisée dans les solutions de détection, prévention et prédiction des maladies, a prévu d’annoncer ses résultats financiers du premier trimestre 2025 le 1er mai 2025, après la clôture du marché.
La société tiendra une conférence téléphonique avec la direction à 13h30 PT / 16h30 ET le même jour. Les investisseurs pourront accéder aux versions en direct et archivées de la conférence via la section 'Quarterly Results' du site investisseurs d’iRhythm à l’adresse investors.irhythmtech.com.
iRhythm Technologies (NASDAQ:IRTC), ein Digital-Healthcare-Unternehmen, das sich auf Lösungen zur Erkennung, Prävention und Vorhersage von Krankheiten spezialisiert hat, hat die Veröffentlichung der Finanzergebnisse für das erste Quartal 2025 für den 1. Mai 2025 nach Börsenschluss geplant.
Das Unternehmen wird am selben Tag um 13:30 Uhr PT / 16:30 Uhr ET eine Telefonkonferenz mit dem Management abhalten. Investoren können sowohl die Live- als auch die aufgezeichnete Version der Telefonkonferenz über den Bereich 'Quarterly Results' auf der Investorenseite von iRhythm unter investors.irhythmtech.com abrufen.
- None.
- None.
SAN FRANCISCO, April 17, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the first quarter 2025 after the close of trading on Thursday, May 1, 2025. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.
Investor Contact
Stephanie Zhadkevich
investors@irhythmtech.com
Media Contact
Kassandra Perry
irhythm@highwirepr.com
FAQ
When will iRhythm Technologies (IRTC) release Q1 2025 earnings?
What time is IRTC's Q1 2025 earnings conference call?
How can investors access IRTC's Q1 2025 earnings call?
What does iRhythm Technologies (IRTC) specialize in?
